Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Cell ; 107(1): 9-12, 2001 Oct 05.
Article in English | MEDLINE | ID: mdl-11595180

ABSTRACT

Studies on several recently discovered error-prone DNA polymerases reveal novel structures that may explain the low fidelity of this general class of enzymes, a number of which are involved in the replicative bypass (translesion synthesis) of base damage in DNA.


Subject(s)
DNA-Directed DNA Polymerase/chemistry , DNA-Directed DNA Polymerase/metabolism , Amino Acid Sequence , Crystallography, X-Ray , DNA Damage , DNA Repair , DNA Replication , Humans , Models, Molecular , Molecular Sequence Data , Mutation , Protein Conformation , Protein Structure, Tertiary , Sequence Alignment
2.
J Biol Chem ; 276(1): 92-8, 2001 Jan 05.
Article in English | MEDLINE | ID: mdl-11024016

ABSTRACT

The Escherichia coli dinB gene encodes DNA polymerase (pol) IV, a protein involved in increasing spontaneous mutations in vivo. The protein-coding region of DINB1, the human ortholog of DNA pol IV, was fused to glutathione S-transferase and expressed in insect cells. The purified fusion protein was shown to be a template-directed DNA polymerase that we propose to designate pol kappa. Human pol kappa lacks detectable 3' --> 5' proofreading exonuclease activity and is not stimulated by recombinant human proliferating cell nuclear antigen in vitro. Between pH 6.5 and 8.5, human pol kappa possesses optimal activity at 37 degrees C over the pH range 6.5-7.5, and is insensitive to inhibition by aphidicolin, dideoxynucleotides, or NaCl up to 50 mm. Either Mg(2+) or Mn(2+) can satisfy a metal cofactor requirement for pol kappa activity, with Mg(2+) being preferred. Human pol kappa is unable to bypass a cisplatin adduct in the template. However, pol kappa shows limited bypass of an 2-acetylaminofluorene lesion and can incorporate dCTP or dTTP across from this lesion, suggesting that the bypass is potentially mutagenic. These results are consistent with a model in which pol kappa acts as a specialized DNA polymerase whose possible role is to facilitate the replication of templates containing abnormal bases, or possessing structurally aberrant replication forks that inhibit normal DNA synthesis.


Subject(s)
DNA Polymerase beta/isolation & purification , DNA Polymerase beta/metabolism , DNA-Directed DNA Polymerase , Proteins/isolation & purification , Proteins/metabolism , Acetoxyacetylaminofluorene/metabolism , Acetoxyacetylaminofluorene/pharmacology , Alkylating Agents/metabolism , Alkylating Agents/pharmacology , Baculoviridae/genetics , Cisplatin/metabolism , DNA Adducts/metabolism , DNA Damage/drug effects , DNA Damage/genetics , DNA Polymerase beta/chemistry , DNA Polymerase beta/genetics , Exonucleases/metabolism , Humans , Hydrogen-Ion Concentration , Mutagenesis/drug effects , Mutagenesis/genetics , Mutation , Proliferating Cell Nuclear Antigen/pharmacology , Proteins/chemistry , Proteins/genetics , Recombinant Fusion Proteins/metabolism , Templates, Genetic
4.
Cancer Res ; 59(17): 4363-8, 1999 Sep 01.
Article in English | MEDLINE | ID: mdl-10485484

ABSTRACT

The sequence specificity and covalent structure of the lesion caused by the DNA interstrand cross-linking reaction of N,N'-bis(2-chloroethyl)-nitrosourea (BCNU) were investigated using synthetic oligonucleotides. The efficiency of interstrand cross-linking was found to parallel the efficiency of monoadduct formation, preferring deoxyguanosine-deoxycytidine-rich duplexes and, particularly, runs of deoxyguanosine. No explicit sequence specificity was observed. Enzymatic digestion of purified, interstrand cross-linked DNA returned primarily the unmodified deoxynucleosides, along with 1-[N3-deoxycytidyl]-2-[N1-deoxyguanosyl]ethane. This substance was characterized by comparison of its mass spectrum, high-pressure liquid chromatography retention time, and UV spectrum to an authentic standard prepared by chemical synthesis. These studies provide the first direct evidence that BCNU has no strong sequence preference for interstrand cross-linking and that substance 4, which has been previously isolated from BCNU-treated DNA, derives from alkylation on opposite strands of DNA. The lack of sequence preference and lesion structure together suggest that one source of BCNU interstrand cross-links is linkage of deoxyguanosine and deoxycytidine partners from a single bp.


Subject(s)
Antineoplastic Agents, Alkylating/metabolism , Carmustine/metabolism , DNA/metabolism , Deoxycytidine/metabolism , Deoxyguanosine/metabolism , Oligonucleotides/metabolism , Animals , DNA/chemistry , Mice
SELECTION OF CITATIONS
SEARCH DETAIL
...